Lupin Limited
Climate Impact & Sustainability Data (2021-04 to 2022-03, 2022-04 to 2023-03, 2023-04 to 2024-03, 2023-2024, 2023-24)
Reporting Period: 2021-04 to 2022-03
Environmental Metrics
ESG Focus Areas
- Environmental Performance and Climate Change
- Employment Practices
- Supply Chain Management
- Governance
- Community Engagement
- Product and Consumer
Environmental Achievements
- GHG emissions savings of 4,341,896 tCO2e
- Increase in renewable energy utilization by 5.30 MW at 2 sites
- Achieved Zero Liquid Discharge status in almost 50% of Indian sites
- Total water recovery in India of 695,008 KL
- Luforbec® Achieves Carbon Neutrality Certification
Social Achievements
- Launched Lupin Diagnostics
- Launched Lives pillar as part of CSR focused on improving health in the communities we serve
- Total CSR expenditure on Women Empowerment INR 25 Mn
- Public Relations engagement that spanned over 27 cities
- Acquired Southern Cross Pharma in Australia
Governance Achievements
- Goa facility upgraded to a satisfactory VAI status by US FDA
- Formalized Human Rights Policy
- Established Third-Party Code of Conduct
- Settled 15 patent litigations in the United States
Climate Goals & Targets
- Reduce Scope 1 and Scope 2 GHG emissions by 15% from 2019-20 levels by 2030
- Recycling 50% of total water withdrawal in operations by 2025
- 60% of hazardous waste generated in Indian operations to be sent to cement plants for co-processing by 2025
Environmental Challenges
- Rising competition, declining prices and input cost pressures in the U.S.
- Inflationary pressures for essential raw materials and intermediates
- Decline in demand for acute therapy products (especially cephalosporins) affecting API business
- Product recalls, penalties on failures to supply due to supply chain disruptions
- One-time settlement of claims on account of Glumetza, and impairment of Solosec and certain IP from Gavis
Mitigation Strategies
- Cost reduction/rationalization initiatives across the value chain
- Focus on complex generics (inhalation, injectables, biosimilars)
- Optimization of costs
- Integrated Business Planning (IBP) process for U.S. supply chain
- ESG focused risk assessment for critical suppliers
Supply Chain Management
Responsible Procurement
- Third-Party Code of Conduct
- ESG focused risk assessment for critical suppliers
- Project Inspire to optimize procurement costs
Climate-Related Risks & Opportunities
Physical Risks
- Extreme weather events, floods
Transition Risks
- Regulatory changes, market shifts
Opportunities
- Development of energy-efficient products
Reporting Standards
Frameworks Used: IIRC Integrated Reporting Framework, SASB guidance for Biotechnology & Pharmaceuticals sector, GRI Standards, BRSR mandate
Certifications: ISO 27001:2013 (Information Security), ISRS, 8th edition (4 sites)
Third-party Assurance: B S R & Co. LLP
Sustainable Products & Innovation
- Luforbec® (carbon neutral)
Awards & Recognition
- India Pharma Award for Excellence in CSR
- Excellence in CSR Award at Manufacturing Today Conference
- Asia Pacific Bioprocessing Excellence Awards 2022
- ETHealthworld India Pharma Awards
- India Pharma Awards 2021
- E4M Health MarCom Awards
- Guinness World Record for largest book sentence
- India Health and Wellness Summit Award
- Best Place to Work in Philippines
- ATD BEST Awards 2022
- MarTech Leadership Summit Award
- Brand of the Year by Global Business Forum
- IHW Council and GOI NITI Ayog Award
- Velocity Award 2021
- CIMS India Award
- IHW Patient First Awards 2022
- ITR Asia-Pacific Tax Awards 2021
Reporting Period: 2022-04 to 2023-03
Environmental Metrics
ESG Focus Areas
- Not disclosed
Environmental Achievements
- Not disclosed
Social Achievements
- Not disclosed
Governance Achievements
- Not disclosed
Climate Goals & Targets
- Not disclosed
- Not disclosed
- Not disclosed
Environmental Challenges
- Not disclosed
Mitigation Strategies
- Not disclosed
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: IIRC's International Integrated Reporting Framework, GRI Standards 2021, SEBI Circular no. SEBI/HO/CFD/CMD-2/P/CIR/2021/562, National Guidelines on Responsible Business Conduct, 2019
Certifications: Null
Third-party Assurance: DNV Business Assurance India Private Limited
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2023-04 to 2024-03
Environmental Metrics
ESG Focus Areas
- CSR
- Human Resources
- Risk Management
- Corporate Governance
Environmental Achievements
- Installed ATCS for heat pumps, EC fans in AHU units, screw press sludge dryer, replaced chilled water system, installed IFC in compressed air network, electronically commuted drive for continuous running AHUs, Briquette boiler, replaced conventional blowers with energy efficient ones, installed centrifugal pumps along with VFD, installed VFD for cooling tower pumps, chilled water and heat pumps, installed automatic tube cleaning system, optimised steam generation and distribution system by using blowdown heat recovery system, installed continuous flow reactors, installed efficient LED lights, installed steam operated pumping traps, installed efficient heat pumps, installed Briquette boiler, installed solar roof-top, installed biomass boiler, commissioned agro boiler, open access purchased for renewable wind power energy.
Social Achievements
- Reached out to over 1.57 million beneficiaries in more than 4771 villages across eight states in India through Lupin Human Welfare and Research Foundation (LHWRF), implemented Prevention of Sexual Harassment Policy covering all genders.
- All policies, systems, technologies and business functions aligned with best industry standards. People-first approach providing best-in-class work environment and advanced learning initiatives.
Governance Achievements
- Continued commitment to adhere to the best standards of corporate governance and ethical practices. Annual performance evaluation of the Board, its committees and of individual directors carried out. Robust Vigil mechanism/Whistleblower policy in place.
Climate Goals & Targets
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: BRSR Core
Third-party Assurance: DNV Business Assurance India Private Limited
Reporting Period: 2023-2024
Environmental Metrics
Climate Goals & Targets
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2023-24
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Reduced 20.8% of scope 1 and scope 2 emissions in global operations
- Recycled and reused 43.8% of total water withdrawn in Indian sites
- Sent 7,332 MT (89.4%) of incinerable hazardous waste for co-processing in FY24
Social Achievements
- Secured over 80+ registrations of anti-TB and ARV medicines
- Launched three patient assistance programs benefitting 29,383 patients
- Educated 557,013 patients and 9,247 doctors
- Achieved an employee satisfaction score of 80%
Governance Achievements
- Zero class I recalls
- 100% completion of mandatory training for all employees on Data Integrity SOP and annual CGMP training across manufacturing sites
Climate Goals & Targets
- Not disclosed
- Diversity target: 15% women employees across all business units by 2030
- Conduct accessibility audit for PWD for all India locations by 2030
- Achieve 50,000 hours of employee volunteering by 2030
- Zero sites with Warning Letter status by FY25
- Reduce direct and indirect GHG emissions by 38% by 2030
- Recycle 50% of total water withdrawn in Indian sites by 2025
- Redirect 70% of total incinerable hazardous waste generated in operations in India for co-processing by 2025
- Achieve & maintain an employee satisfaction score of 80% or higher on annual surveys by 2025
Environmental Challenges
- Pollution from manufacturing processes
- Water management in areas of water stress
- Pharmaceuticals in the environment/Antimicrobial Resistance (AMR)
- Waste minimization
- Occupational Health and Safety
- Human Rights
- Data Privacy and Protection
Mitigation Strategies
- Pollution control measures, monitoring air and GHG emissions, wastewater generation, efficient water consumption, increasing water recovery, increasing recycling and reuse of waste, co-processing of hazardous waste
- Targets to recycle water consumption by 50% by 2030, Zero Liquid Discharge at 6 sites, responsible water use in high water stress areas
- Assessing ecological impact of APIs, analyzing antimicrobial contents in treated water discharges, Zero Liquid Discharge plants, life cycle assessments
- 3R principle of ‘Reduce, Reuse and Recycle’, sending waste to third parties for recycling/disposal
- ISO 18001 certification, management systems for avoiding unsafe incidents, regular training, reporting near misses
- Policies and safeguards to ensure human rights protection, code of conduct, redressal mechanisms
- ISO 27001 certification, regular data checks, employee training on data handling
Supply Chain Management
Supplier Audits: ~300 Tier 1 suppliers
Responsible Procurement
- Third Party Code of Conduct mandating sustainability criteria
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: NGRBC
Certifications: ISO 14001, ISO 45001, ISO 27001, ISO 8 Class 100,000 Clean Rooms Standards, Good Manufacturing Practice (GMP)
Third-party Assurance: DNV Business Assurance India Private Limited
Sustainable Products & Innovation
- Luforbec (carbon neutral inhaler)
Awards & Recognition
- GOLD LEED for Mandideep facility